台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    108.0
  • 漲跌
    ▲6.5
  • 漲幅
    +6.40%
  • 成交量
    419
  • 產業
    上櫃 生技醫療類股▲2.09%
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-亞東 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

亞東 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/06/2000.002103.25105.00-2372-0.54%
2024/06/192100.3000.00101.5023740.53%
2024/06/1800.001108.50104.50-1364-0.27%
2024/06/17199.8000.00108.0013530.28%
2024/06/0400.00396.1796.00-3316-0.95%
2024/05/30192.0000.0090.9013200.31%
2024/05/29296.5000.0094.5023190.63%
2024/05/2800.001100.00100.00-1312-0.32%
2024/05/27199.1000.00100.0013070.33%
2024/05/2300.00395.27100.50-3286-1.05%
2024/05/22393.9000.0091.5032601.15%
2022/04/2600.00115.2514.80-1129-0.77%
2022/04/25116.1000.0015.3011270.79%
2022/04/2200.00515.6515.65-5121-4.11%
2022/04/21515.3200.0015.0051164.30%
2022/04/1900.00115.8515.35-1105-0.95%
2022/04/18115.5500.0016.951921.08%
2021/09/3000.00115.8515.90-191-1.09%
2021/09/15115.7000.0015.5511010.98%
2021/05/1200.00217.7517.80-2377-0.53%
2021/04/2700.00017.7017.8003490.00%
2021/04/2600.00017.1017.3003460.00%
2021/04/1300.00218.2018.20-2322-0.62%
2021/04/12317.9500.0018.8032941.02%
2021/01/0700.00216.8016.75-2346-0.58%
2021/01/06216.8500.0016.8023480.57%
2020/12/09218.0000.0017.8523530.57%
2020/11/1100.001520.3320.30-15425-3.52%
2020/11/051518.9900.0018.95154423.39%
2020/10/22123.052022.6021.20-19561-3.38%
2020/10/2000.00119.8019.80-1546-0.18%
2020/10/192017.8000.0018.00205573.59%
2020/09/18119.0000.0018.9011,3560.07%
2020/09/1500.00119.1019.15-11,377-0.07%
2020/09/1100.00218.1018.10-21,417-0.14%
2020/08/27120.6000.0020.5511,9220.05%
2020/08/2100.00120.5521.15-12,047-0.05%
2020/08/20122.00121.2019.7002,1210.00%
2020/08/19222.0000.0021.8022,1280.09%
2020/08/0500.00425.4525.05-42,289-0.17%
2020/08/04425.34425.3125.5002,2780.00%
2020/08/03425.35125.2526.4032,2730.13%
2020/07/31125.10324.8524.65-22,263-0.09%
2020/07/30425.41325.6525.2512,2720.04%
2020/07/29324.72125.0025.5522,2730.09%
2020/07/2700.00127.4024.90-12,248-0.04%
2020/07/24127.80228.1027.00-12,236-0.04%
2020/07/23229.0000.0028.8022,2330.09%
2020/07/22129.00129.9530.0002,2040.00%
2020/07/2100.001126.9627.45-112,149-0.51%
2020/07/20524.24224.6025.0032,1090.14%
2020/07/17326.78126.5526.1522,0680.10%
2020/07/16329.18129.2029.0522,0180.10%
2020/07/15529.65530.4630.8001,9830.00%
2020/07/14329.9500.0029.6031,9070.16%
2020/07/13131.20630.9831.55-51,793-0.28%
2020/07/10528.60228.7028.7031,6660.18%
2020/07/0900.000.526.1026.10-0.51,530-0.03%
2020/07/0800.000.823.7523.75-0.81,516-0.05%
2020/07/07121.7500.0021.6011,5050.07%
2020/06/1900.00322.1022.20-31,393-0.22%
2020/06/1800.00422.9022.85-41,372-0.29%
2020/06/17325.9000.0025.3531,3500.22%
2020/06/16425.68026.0025.9041,2940.31%
2020/06/1500.00223.6824.20-21,207-0.17%
2020/06/12119.0000.0022.0011,1240.09%
2020/06/11220.38220.5321.0001,0770.00%
2020/06/10118.25218.5019.10-1985-0.10%
2020/05/29118.5000.0018.5019730.10%
2020/05/28117.552317.6918.50-22978-2.25%
2020/05/25119.5500.0019.6519350.11%
2020/05/222017.45117.9017.90199302.04%
2020/05/15111.8500.0011.8017890.13%
2020/05/1200.00111.5511.60-1783-0.13%
2020/05/0400.00212.2012.40-2724-0.28%
2020/04/2429.6000.009.6026960.29%
2020/02/2600.00114.0014.05-1321-0.31%
2019/10/0400.00111.0510.85-1146-0.68%
2019/08/1200.00710.2410.20-7151-4.63%
2019/08/08211.00110.8010.7511480.67%
2019/08/06110.8500.0010.6011490.67%
2019/08/01211.0500.0010.8021501.33%
2019/07/30211.1000.0010.8021481.35%
2019/07/19111.8000.0011.7511340.74%
2019/04/1000.001012.3512.40-10154-6.49%
2019/03/28812.5000.0012.4081505.32%
2019/03/27212.5000.0012.5021501.33%
2019/03/1100.00212.4012.45-2130-1.53%
2019/01/29212.8000.0012.7021111.79%
2019/01/22212.9800.0012.9021071.86%
2018/10/2600.00212.1012.15-289-2.24%
2018/08/2000.00117.0517.00-1117-0.85%
2018/08/1300.00118.4018.00-1119-0.83%
2018/07/1900.00319.1019.00-3144-2.08%
2018/06/2500.00117.4517.45-1400-0.25%
2018/05/18118.2500.0018.2513980.25%
2018/04/16121.7000.0021.3513290.30%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音